Inventor · disambiguated record
Valery Krasnoperov
Also filed as: KRASNOPEROV VALERY · KRASNOPEROV VALERY G
10 granted patents·10 pending applications·34 citations·filing 1997–2022
84Inventor score
Top patents by PatentIndex Score
20 records- 0185US7906116B2Methods for using and identifying modulators of Delta-like 4GILL PARKASH·Filed 2007·Granted Mar 15, 2011·13 cites·6 claims
- 0283US7862816B2Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2004·Granted Jan 4, 2011·15 cites·13 claims
- 0379US7381410B2Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2004·Granted Jun 3, 2008·6 cites·34 claims
- 0465US2010261653A1Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 0561US8273858B2Polypeptide compounds for inhibiting angiogenesis and tumor growthKRASNOPEROV VALERY·Filed 2008·Granted Sep 25, 2012·0 cites·22 claims
- 0660US9533026B2Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2013·Granted Jan 3, 2017·0 cites·7 claims
- 0758US8063183B2Polypeptide compounds for inhibiting angiogenesis and tumor growthKRASNOPEROV VALERY·Filed 2006·Granted Nov 22, 2011·0 cites·28 claims
- 0858US2025123284A1Diagnostic methods for cancer using ephrinb2 expressionVASGENE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0955US8975377B2Cancer treatment using humanized antibodies that bind to EphB4GILL PARKASH·Filed 2008·Granted Mar 10, 2015·0 cites·8 claims
- 1055US2012277162A1Polypeptide compounds for inhibiting angiogenesis and tumor growthKRASNOPEROV VALERY·Filed 2012·Application pending·0 cites
- 1155US2006204512A1Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1255US2024156908A1USE OF sEphB4-HSA FUSION PROTEIN AS A FIRST-LINE THERAPY IN CANCER TREATMENTKRASNOPEROV VALERY·Filed 2022·Application pending·0 cites
- 1353US2011129482A1Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 1448US7977463B2Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2005·Granted Jul 12, 2011·0 cites·31 claims
- 1548US2022249621A1TREATMENT OF CANCERS USING sEphB4-HSA FUSION PROTEINSVASGENE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1645US2007218061A1Use of ephrinb2 directed agents for the treatment or prevention of viral infectionsVASGENE THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1745US2022153791A1Ephb4-ephrin b2 receptor ligand pair as a novel marker for the treatment of prostate cancerVASGENE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1844US8981062B2Polypeptide compounds for inhibiting angiogenesis and tumor growthKRASNOPEROV VALERY·Filed 2011·Granted Mar 17, 2015·0 cites·23 claims
- 1942US2011213127A1Methods for using and identifying modulators of delta-like 4VASGENE THERAPEUTICS INC·Filed 2011·Application pending·0 cites
- 2025US6630345B2Nucleic acids encoding a calcium independent receptor of α-latrotoxin, characterization and uses thereofUNIV NEW YORK·Filed 1997·Granted Oct 7, 2003·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Valery Krasnoperov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →